Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Dec 2025 is -21.62% vs -86.98% in Dec 2024
Consolidate Net Profit
YoY Growth in quarter ended Dec 2025 is 35.36% vs -332.80% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Dec 2025 is 49.53% vs -241.20% in Dec 2024
Interest
YoY Growth in quarter ended Dec 2025 is 9.20% vs 35.94% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024
Compare Quarterly Results Of Sutro Biopharma, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Dec 2025 is 19.59% vs -84.77% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -21.62% vs -86.98% in Dec 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 17.75% vs -394.78% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 35.36% vs -332.80% in Dec 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Dec 2025 is 13.51% vs -317.65% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 49.53% vs -241.20% in Dec 2024
Quarterly - Interest
QoQ Growth in quarter ended Dec 2025 is -2.06% vs 1.04% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 9.20% vs 35.94% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024






